Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP645657.RAP6WYwXHsH91PkvAwBs2uvv4fLBJi8MUzUwS3Cp2CIl8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP645657.RAP6WYwXHsH91PkvAwBs2uvv4fLBJi8MUzUwS3Cp2CIl8130_assertion type Assertion NP645657.RAP6WYwXHsH91PkvAwBs2uvv4fLBJi8MUzUwS3Cp2CIl8130_head.
- NP645657.RAP6WYwXHsH91PkvAwBs2uvv4fLBJi8MUzUwS3Cp2CIl8130_assertion description "[The ERCC2 genotype appears as an important predictive factor of the survival of patients treated with oxaliplatin in first-line therapy for metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645657.RAP6WYwXHsH91PkvAwBs2uvv4fLBJi8MUzUwS3Cp2CIl8130_provenance.
- NP645657.RAP6WYwXHsH91PkvAwBs2uvv4fLBJi8MUzUwS3Cp2CIl8130_assertion evidence source_evidence_literature NP645657.RAP6WYwXHsH91PkvAwBs2uvv4fLBJi8MUzUwS3Cp2CIl8130_provenance.
- NP645657.RAP6WYwXHsH91PkvAwBs2uvv4fLBJi8MUzUwS3Cp2CIl8130_assertion SIO_000772 18085999 NP645657.RAP6WYwXHsH91PkvAwBs2uvv4fLBJi8MUzUwS3Cp2CIl8130_provenance.
- NP645657.RAP6WYwXHsH91PkvAwBs2uvv4fLBJi8MUzUwS3Cp2CIl8130_assertion wasDerivedFrom befree-2016 NP645657.RAP6WYwXHsH91PkvAwBs2uvv4fLBJi8MUzUwS3Cp2CIl8130_provenance.
- NP645657.RAP6WYwXHsH91PkvAwBs2uvv4fLBJi8MUzUwS3Cp2CIl8130_assertion wasGeneratedBy ECO_0000203 NP645657.RAP6WYwXHsH91PkvAwBs2uvv4fLBJi8MUzUwS3Cp2CIl8130_provenance.